Sign In
Buy TEVA
$34.72
+0.290 (+0.84%)
At Close: Aug 05, 2026
TEVA Stock Declines Despite Q4 Earnings and Sales Beat
11:20am, Thursday, 11'th Feb 2021
TEVA beats on fourth-quarter earnings and sales. It issues its financial guidance for 2021.
8 Cheap Stocks Under $20 That Could Double
09:05am, Thursday, 11'th Feb 2021
Even though the market has been on fire recently, that doesn't mean you're too late to pick up cheap stocks under $20 with 2x (or more) potential. The post 8 Cheap Stocks Under $20 That Could Double a
Teva in Talks to Help Make Covid Vaccines, CEO Says
07:34pm, Wednesday, 10'th Feb 2021
Feb.10 -- Teva Pharmaceutical Industries Ltd. Chief Executive Officer Kare Schultz discusses the company's plans to produce and distribute Covid-19 vaccines and says Teva is ready to settle thousan
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on Q4 2020 Results - Earnings Call Transcript
01:05pm, Wednesday, 10'th Feb 2021
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on Q4 2020 Results - Earnings Call Transcript
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
11:53am, Wednesday, 10'th Feb 2021
Teva Pharmaceuticals CEO Kare Schultz joins "Squawk on the Street" to discuss the rollout of Covid-19 vaccines in Israel. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https:
TEVA Q4 Earnings & Sales Beat Estimates, Stock Rises
10:10am, Wednesday, 10'th Feb 2021
TEVA beats earnings and sales for fourth-quarter 2020. It issues its financial guidance for 2021.
Teva's stock rallies 2% on earnings
07:48am, Wednesday, 10'th Feb 2021
Shares of Teva Pharmaceutical Industries Ltd. gained 2.7% in premarket trading on Wednesday after the drugmaker beat expectations for revenue and adjusted earnings per share in the final quarter of 20
Recap: Teva Pharmaceutical Q4 Earnings
07:16am, Wednesday, 10'th Feb 2021
Shares of Teva Pharmaceutical Indus (NYSE:TEVA) moved higher by 3.7% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 9.68% over the past year to
Should Value Investors Buy Teva Pharmaceutical Industries Ltd. (TEVA) Stock?
12:53pm, Tuesday, 09'th Feb 2021
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
TEVA Gears Up to Report Q4 Earnings: What's in the Cards?
11:23am, Monday, 08'th Feb 2021
On TEVA's fourth-quarter conference call, investors focus is likely to be on updates on the extent to which the resurgence of COVID-19 infection rates impacted sales of its products.
5 Deeply Discounted Stocks to Buy for a Biden Bull Market
05:51am, Sunday, 31'st Jan 2021
The conditions are ripe for a strong bull market to take shape under the new administration, and these ultracheap stocks could be direct beneficiaries.
ITEQ Is A Way To Invest In Israeli Innovation
12:23pm, Tuesday, 19'th Jan 2021
ITEQ Is A Way To Invest In Israeli Innovation
3 Turnaround Stocks That Will Make You Richer in 2021
06:06am, Sunday, 17'th Jan 2021
Things are looking up for these beaten-down value plays in the new year.
Teva Stock Pops on Generic NuvaRing® Announcement
10:32am, Friday, 15'th Jan 2021
The shares of Teva Pharmaceutical Industries Ltd (NYSE:TEVA) are up 0.4% at $11.54 this morning, after the company announced plans to launch a generic version of Merck's (MRK) birth control device kno
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on 39th Annual JP Morgan Healthcare Conference Transcript
12:51pm, Wednesday, 13'th Jan 2021
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on 39th Annual JP Morgan Healthcare Conference Transcript
